title: Letter by van der Linden et al regarding article, "Effect of clopidogrel premedication in off-pump cardiac surgery: are we forfeiting the benefits of reduced hemorrhagic sequelae?".
authors.forename: Jan
authors.initials: J
authors.lastname: van der Linden
authors.forename: Gabriella
authors.initials: G
authors.lastname: Lindvall
authors.forename: Ulrik
authors.initials: U
authors.lastname: Sartipy
mesh_terms: D007611:Aprotinin / Q000627:therapeutic use; D000077144:Clopidogrel; D047549:Coronary Artery Bypass, Off-Pump / Q000009:adverse effects*; D006470:Hemorrhage / Q000139:chemically induced* / Q000517:prevention & control; D006490:Hemostatics / Q000627:therapeutic use; D006801:Humans; D010975:Platelet Aggregation Inhibitors / Q000009:adverse effects*; D011292:Premedication; D013988:Ticlopidine / Q000009:adverse effects / Q000031:analogs & derivatives*
chemical_list: D006490:Hemostatics; D010975:Platelet Aggregation Inhibitors; D007611:Aprotinin; D000077144:Clopidogrel; D013988:Ticlopidine